Blood Samples for Genetic Analysis in Cancer Patients
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
Observational Study
Prostate Cancer
Breast Cancer
Lung Cancer
Ovarian Cancer
Lymphoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,100 (estimated)
- Sponsor
- National Cancer Institute (NCI) · NIH
Who this trial is looking for
This trial is looking for people with cancer who are receiving treatment at the National Cancer Institute. Participants will provide a blood or cheek swab sample to study genetic differences that may affect cancer treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I am currently enrolled in a clinical trial at NIH
- I am receiving treatment for cancer
- I am at least 3 years old
- I can understand and sign the consent form
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Background:
\- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.
Objectives:
\- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* INCLUSION CRITERIA:
* Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.
* Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.
* Age \>= 3 years old
EXCLUSIO…
Contacts